UK markets closed

Kala Pharmaceuticals, Inc. (KALA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
6.30+0.11 (+1.78%)
At close: 04:00PM EDT
6.75 +0.45 (+7.14%)
After hours: 06:10PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2221
Avg. Estimate-2.89-2.86-10.17-11.5
Low estimate-3.14-3.1-11.34-11.5
High estimate-2.64-2.62-9-11.5
Year ago EPS-6.99-4.36-17.35-10.17
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2221
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-4.43-3.19-2.15-3.62
Actual EPS-6.99-4.36-3.41-3.18
Difference-2.56-1.17-1.260.44
Surprise %-57.80%-36.70%-58.60%12.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-2.89-2.86-10.17-11.5
7 days ago-2.89-2.86-10.17-11.5
30 days ago-3.64-3.62-11.86-11.5
60 days ago-3.64-3.62-11.86-11.5
90 days ago-3.64-3.62-11.86-11.5
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days221N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesKALAIndustrySector(s)S&P 500
Current qtr.58.70%N/AN/AN/A
Next qtr.34.40%N/AN/AN/A
Current year41.40%N/AN/AN/A
Next year-13.10%N/AN/AN/A
Next 5 years (per annum)40.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A